查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363510

生物植入物市場規模、型態和趨勢分析報告：按產品、按給藥、按用途、按地區和細分趨勢，2023-2030

Biological Implants Market Size, Share & Trends Analysis Report By Product (Autografts, Allografts), By Mode of Administration (Surgical, Injectable), By Application (Cardiovascular Implants), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 147 Pages | 商品交期: 2-10個工作天內

價格

生物植入物市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球生物植入物市場規模將達到136.1億美元，2023年至2030年年複合成長率為7.2%。

生物植入物市場受到各種臨床用途（包括心血管、整形外科和其他軟組織修復）的重組手術中擴大採用移植物和器官替代的推動。使用這些產品的主要挑戰是採用能夠特異性適應周圍環境生物學以促進再生和修復的材料。為了克服這項挑戰，人們正在努力從生物來源開發此類設備，從而影響未來的工業成長。

複合材料移植製程的改進有望透過帶來整個移植過程的進步，在解決斷指再植入問題上發揮重要作用。此外，該市場主要參與企業之間日益激烈的競爭是加速成長的影響要素之一。

生物植入物市場報告亮點

  • 根據移植物來源或供體，提供的產品分為自體移植物、同種異體移植物和異質骨移植。到 2022 年，異質骨移植將佔銷售額的 50% 以上。然而，同種異體移植物源自同一物種，發生異物免疫移植反應的機率要低得多，這會影響採用率，預計會快速成長。
  • 生物製藥有多種用途，包括心血管、整形外科和其他軟組織植入物。由於牙科領域產品的高使用率，軟組織產品在 2022 年佔據最大佔有率。儘管心血管植入物在當前情況下的普及最低，但對生物來源的心血管支架和瓣膜的需求預計將成長，從而增加該細分收益。
  • 據估計，手術給藥在手術給藥和注射給藥中所佔比例最大。手術植入微創技術的引入也是促進該細分市場成長的關鍵要素之一。
  • 北美地區由於市場參與企業廣泛且人們的意識層級較高，以50.3%的銷售佔有率佔據市場主導地位。
  • 亞太地區預計將在未來年度出現最快的成長，由於目標人口的存在和醫療基礎設施的快速改善，將推動對組織工程產品和生物植入物的需求。
  • 該行業的一些主要公司包括 Medtronic、NuVasive, Inc、Stryker Corporation、Conmed Corporation、CryoLife、Edwards LifeSciences Corporation、Acelity、Integra LifeSciences Corporation、Allergan Plc、RTI Surgical、IOP Ophthalmics、Organogenesis Inc 、BioPolymer GmbO &Coris。 Therapeutics、Baxter International、Vericel、Aplhatec Spine Inc、Maxigen Biotech Inc、Auto Tissue Berlin GmbH、MiMedx Group, Inc.
  • 這些參與者正在製定各種業務策略，以提高各自的滲透率並提高其在市場中的影響力。這些策略包括透過參與新產品開發和聯合活動來擴大地域範圍，以獲取更大的收益佔有率。例如，2016 年 4 月，Stryker Corporation收購了Stanmore Implants Worldwide Limited。這使該公司能夠為整形外科腫瘤外科醫生提供差異化技術，預計將在預測期內推動成長。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 生物植入物市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 生物植入市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 生物植入：按產品的估算和趨勢分析

  • 生物植入市場：重點
  • 生物醫學植入物市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 自體移植物
  • 同種異體移植物
  • 異質骨移植

第5章 生物植入物：按用途估算和趨勢分析

  • 生物植入市場：重點
  • 生物醫學植入物市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 心血管植入物
  • 整形外科植入物
  • 其他軟組織植入物

第6章 生物植入物：按給藥的估計和趨勢分析

  • 生物植入市場：重點
  • 生物醫學植入物市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 外科手術
  • 注射

第7章 生物植入市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的生物植入物市場：重點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Integra LifeSciences
    • NuVasive, Inc.
    • Edwards Lifesciences Corporation
    • Stryker
    • LifeCell International Pvt. Ltd.
    • Medtronic
    • Osteotec Limited
    • RTI Surgical
    • BioPolymer GmbH & Co KG
    • Johnson & Johnson Private Limited
    • Baxter
    • Vericel
    • ATEC Spine, Inc
    • Artivion, Inc
    • Maxigen Biotech Inc.
    • Implandata Ophthalmic Products GmbH
    • CONMED Corporation
    • AbbVie Inc.
    • BioTissue
    • Auto Tissue Berlin GmbH
    • MIMEDX Group, Inc.
    • Organogenesis Inc.
    • Smith+Nephew
Product Code: GVR-1-68038-270-9

Biological Implants Market Growth & Trends:

The global biological implants market size is expected to reach USD 13.61 billion by 2030, according to a new report by Grand View Research, Inc.., registering a CAGR of 7.2% from 2023 to 2030. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Modification in the process of composite grafting is expected to play a crucial role in tackling reimplantation of amputated fingertips by bringing development in the overall process of grafting. Moreover, rising competition amongst key participants operating in this market is one of the high impact rendering factors to accelerate the growth.

Biological Implants Market Report Highlights:

  • Depending upon the source or donor of grafts, products offered can be categorized into autograft, allografts, and xenografts. Xenografts dominated the revenue share in 2022 with a revenue share of over 50%. However, allografts are expected to witness the fastest growth owing to the fact that they are derived from same species and produce considerably less chances of foreign immune implants reaction, thereby influencing adoption rate.
  • Biological serve various application domains which include cardiovascular, orthopedic, and other soft tissue implants. Soft tissue products accounted for the largest share in 2022 as a result of higher usage of the products in the field of dentistry. Even though cardiovascular implants accounted for lowest penetration in the current scenario, demand for cardiovascular stents and valves obtained from biological source is expected to expand, consequently boosting revenue generation from this segment.
  • Amongst surgical and injectable mode of administration, surgical mode is estimated to hold the larger share, as a consequence of availability of several products administered via this route. Introduction of minimally invasive techniques for surgical incorporation of grafts is also one of the significant factors propelling growth in this segment.
  • North America dominated the market with a revenue share of 50.3% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region.
  • Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.
  • Major players operating in this industry include Medtronic, NuVasive, Inc, Stryker Corporation, Conmed Corporation, CryoLife, Edwards LifeSciences Corporation, Acelity, Integra LifeSciences Corporation, Allergan Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue Berlin GmbH, MiMedx Group, Inc., Biotissue Technologies,
  • These players are undertaking different business strategies to boost their respective penetration and enhance market presence. These strategies include novel product developments and geographic expansion by involving in collaborative activities in order to grab the larger share of revenue. For instance, in April 2016, Stryker Corporation acquired Stanmore Implants Worldwide Limited which is expected to enable the company to provide differentiated technologies to orthopedic oncology surgeons, thus propelling growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Mode of Administration
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Mode of administration outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Biological Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Biological Implants Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Biological Implants: Product Estimates & Trend Analysis

  • 4.1. Biological Implants Market: Key Takeaways
  • 4.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Autografts
    • 4.3.1. Autografts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Allografts
    • 4.4.1. Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Xenografts
    • 4.5.1. Xenografts market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Biological Implants: Application Estimates & Trend Analysis

  • 5.1. Biological Implants Market: Key Takeaways
  • 5.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Cardiovascular Implants
    • 5.3.1. Cardiovascular implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Orthopedic Implants
    • 5.4.1. Orthopedic implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Other Soft Tissue Implants
    • 5.5.1. Other soft tissue implants market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Biological Implants: Mode of Administration Estimates & Trend Analysis

  • 6.1. Biological Implants Market: Key Takeaways
  • 6.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Surgical
    • 6.3.1. Surgical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Injectable
    • 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Biological Implants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Biological Implants Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Integra LifeSciences
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. NuVasive, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Edwards Lifesciences Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Stryker
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. LifeCell International Pvt. Ltd.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Osteotec Limited
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. RTI Surgical
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. BioPolymer GmbH & Co KG
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Johnson & Johnson Private Limited
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Baxter
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Vericel
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. ATEC Spine, Inc
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Artivion, Inc
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Maxigen Biotech Inc.
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives
    • 8.2.16. Implandata Ophthalmic Products GmbH
      • 8.2.16.1. Company overview
      • 8.2.16.2. Financial performance
      • 8.2.16.3. Product benchmarking
      • 8.2.16.4. Strategic initiatives
    • 8.2.17. CONMED Corporation
      • 8.2.17.1. Company overview
      • 8.2.17.2. Financial performance
      • 8.2.17.3. Product benchmarking
      • 8.2.17.4. Strategic initiatives
    • 8.2.18. AbbVie Inc.
      • 8.2.18.1. Company overview
      • 8.2.18.2. Financial performance
      • 8.2.18.3. Product benchmarking
      • 8.2.18.4. Strategic initiatives
    • 8.2.19. BioTissue
      • 8.2.19.1. Company overview
      • 8.2.19.2. Financial performance
      • 8.2.19.3. Product benchmarking
      • 8.2.19.4. Strategic initiatives
    • 8.2.20. Auto Tissue Berlin GmbH
      • 8.2.20.1. Company overview
      • 8.2.20.2. Financial performance
      • 8.2.20.3. Product benchmarking
      • 8.2.20.4. Strategic initiatives
    • 8.2.21. MIMEDX Group, Inc.
      • 8.2.21.1. Company overview
      • 8.2.21.2. Financial performance
      • 8.2.21.3. Product benchmarking
      • 8.2.21.4. Strategic initiatives
    • 8.2.22. Organogenesis Inc.
      • 8.2.22.1. Company overview
      • 8.2.22.2. Financial performance
      • 8.2.22.3. Product benchmarking
      • 8.2.22.4. Strategic initiatives
    • 8.2.23. Smith+Nephew
      • 8.2.23.1. Company overview
      • 8.2.23.2. Financial performance
      • 8.2.23.3. Product benchmarking
      • 8.2.23.4. Strategic initiatives 

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 5 North America biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 9 Canada biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 12 Europe biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 15 Europe biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 19 UK biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 22 France biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 23 France biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 24 France biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 25 Italy biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 28 Spain biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 31 Sweden biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 34 Norway biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 37 Denmark biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 47 China biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 48 China biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 49 China biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 50 India biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 51 India biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 52 India biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 53 Australia biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 56 Thailand biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 57 Thailand biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 59 South Korea biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 62 Latin America biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 65 Latin America biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 69 Mexico biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 72 Argentina biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 85 UAE biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 88 Kuwait biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait biological implants market, by mode of administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Biological implants: Market outlook
  • Fig. 8 Biological implants: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Biological implants market driver impact
  • Fig. 14 Biological implants market restraint impact
  • Fig. 15 Biological implants market strategic initiatives analysis
  • Fig. 16 Biological implants market: Product movement analysis
  • Fig. 17 Biological implants market: Product outlook and key takeaways
  • Fig. 18 Autografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Allografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Xenografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biological implants market: Application movement analysis
  • Fig. 22 Biological implants market: Application outlook and key takeaways
  • Fig. 23 Cardiovascular implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Orthopedic implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other soft tissue implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Biological implants market: Mode of administration movement analysis
  • Fig. 27 Biological implants market: Mode of administration outlook and key takeaways
  • Fig. 28 Surgical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global biological implants market: Regional movement analysis
  • Fig. 31 Global biological implants market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)